These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 69070)

  • 1. Postmenopausal oestrogen replacement and lipids.
    Wallentin L; Larsson-Cohn U
    Lancet; 1977 Jun; 1(8026):1358-9. PubMed ID: 69070
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of oestrogen and progestogen therapy on calcium metabolism in post-menopausal women.
    Gallagher JC; Nordin EC
    Front Horm Res; 1975; 3():150-76. PubMed ID: 1234561
    [No Abstract]   [Full Text] [Related]  

  • 3. [Estrogen metabolism and hormone substitution in the climacteric].
    Göretzlehner G; Kyank H
    Zentralbl Gynakol; 1985; 107(16):977-88. PubMed ID: 2996259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
    Weissberger AJ; Ho KK; Lazarus L
    J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of climacteric syndrome with estriol in practice].
    Heuer D
    Arzneimittelforschung; 1969 Jan; 19(1):121-2. PubMed ID: 5819357
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of a sequential oestrogen-progestin therapy on the plasma level of oestrogens and lipids in post-menopausal women.
    Lillienberg L; Adlercreutz H; Svanborg A
    Acta Endocrinol (Copenh); 1979 Oct; 92(2):319-29. PubMed ID: 494994
    [No Abstract]   [Full Text] [Related]  

  • 7. Estradiol + nomegestrol. Oral contraceptive claimed to be more natural, but presenting no obvious advantages.
    Prescrire Int; 2012 Dec; 21(133):292. PubMed ID: 23373095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative fatty acid composition of lecithin during postmenopausal replacement therapy--a comparison between ethinyl estradiol and estradiol valerate.
    Ottosson UB; Lagrelius A; Rosing U; von Schoultz B
    Gynecol Obstet Invest; 1984; 18(6):296-302. PubMed ID: 6519560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of hirsutism using cyproterone acetate].
    Hammerstein J; Cupceancu B
    Dtsch Med Wochenschr; 1969 Apr; 94(16):829-34. PubMed ID: 4304873
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytologic examination of vaginal smears in postmenopausal women undergoing ethinyl estradiol treatment].
    Damholt V
    Nord Med; 1968 Mar; 79(12):385-8. PubMed ID: 4872510
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aacifemine compared with Equigyne in the therapy of menopause disorders].
    Lambillon J
    Bull Soc R Belge Gynecol Obstet; 1969 Mar; 39(2):135-46. PubMed ID: 5494808
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of natural oestrogen/gestagen therapy on uric acid metabolism in post-menopausal women.
    Gotfredsen A; Christiansen C; Transbøl I
    Maturitas; 1983 Jun; 5(1):9-15. PubMed ID: 6348486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
    Jensen J; Christiansen C; Rødbro P
    N Engl J Med; 1985 Oct; 313(16):973-5. PubMed ID: 4047104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of ethinyl estradiol sulfonate on decreased bladder tonus after the onset of menopause].
    Rettstke U
    Akush Ginekol (Mosk); 1978 Dec; (12):37-8. PubMed ID: 367192
    [No Abstract]   [Full Text] [Related]  

  • 15. Massive enlargement of occluded tubes after postmenopausal treatment with natural estrogens.
    Hammar M; Larsson-Cohn U
    Acta Obstet Gynecol Scand; 1978; 57(2):189-90. PubMed ID: 636861
    [No Abstract]   [Full Text] [Related]  

  • 16. Oestrogen therapy in the peri-menopause: A practical approach.
    Haspels AA
    Acta Endocrinol Suppl (Copenh); 1980; 233():57-61. PubMed ID: 6996406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose tolerance, plasma insulin and lipids in postmenopausal women during sequential oestrogen-progestin treatment.
    Pyörälä K; Pyörälä T; Lampinen V; Taskinen MR
    Acta Obstet Gynecol Scand Suppl; 1971; 9():Suppl 9:28. PubMed ID: 5287100
    [No Abstract]   [Full Text] [Related]  

  • 18. Observations of sequential changes in bone mass in postmenopausal women: a controlled trial of oestrogen and calcium therapy.
    Horsman A; Nordin BE; Gallagher JC; Kirby PA; Milner RM; Simpson M
    Calcif Tissue Res; 1977 May; 22 Suppl():217-24. PubMed ID: 334343
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of an antiestrogen on subfractions of HDL cholesterol during estrogen replacement therapy.
    Ottosson UB; Carlström K; Johansson BG; von Schoultz B
    Gynecol Obstet Invest; 1984; 18(3):140-6. PubMed ID: 6436151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
    Haarbo J; Hassager C; Jensen SB; Riis BJ; Christiansen C
    Am J Med; 1991 May; 90(5):584-9. PubMed ID: 1827568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.